Clinical Trial Update: A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HLX10 with placebo plus chemotherapy in first-line locally advanced or metastatic esophageal squamous cell carcinoma; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN